Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
7.67
-0.55 (-6.69%)
At close: Mar 28, 2025, 4:00 PM
7.30
-0.37 (-4.82%)
Pre-market: Mar 31, 2025, 8:48 AM EDT

Adaptive Biotechnologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Cash & Equivalents
47.9265.0690.03139.07123.44
Upgrade
Short-Term Investments
174.37281.34408.17214564.83
Upgrade
Cash & Short-Term Investments
222.29346.4498.2353.06688.27
Upgrade
Cash Growth
-35.83%-30.47%41.11%-48.70%19.31%
Upgrade
Accounts Receivable
41.7337.9740.0617.4110.05
Upgrade
Other Receivables
1.310.81.42.5
Upgrade
Receivables
43.0338.9740.8618.8112.55
Upgrade
Inventory
8.4414.4514.4519.2614.06
Upgrade
Prepaid Expenses
9.9910.378.6411.6212.04
Upgrade
Total Current Assets
283.75410.19562.15402.75726.91
Upgrade
Property, Plant & Equipment
94.38120.32164.21172.94139.04
Upgrade
Long-Term Investments
33.66--217.15118.53
Upgrade
Goodwill
118.97118.97118.97118.97118.97
Upgrade
Other Intangible Assets
3.435.136.838.5310.23
Upgrade
Other Long-Term Assets
5.186.524.463.012.74
Upgrade
Total Assets
539.38661.13856.62923.341,116
Upgrade
Accounts Payable
7.277.728.083.313.24
Upgrade
Accrued Expenses
20.6720.3924.122.218.92
Upgrade
Current Portion of Long-Term Debt
0.87----
Upgrade
Current Portion of Leases
10.249.389.235.063.53
Upgrade
Current Income Taxes Payable
0.180.060.190.390.37
Upgrade
Current Unearned Revenue
55.6948.6364.1280.4673.32
Upgrade
Other Current Liabilities
3.151.844.072.395.82
Upgrade
Total Current Liabilities
98.0588.02109.79113.81105.2
Upgrade
Long-Term Debt
132.41130.66125.36--
Upgrade
Long-Term Leases
79.1589.3998.77106.69104.33
Upgrade
Long-Term Unearned Revenue
27.2644.7958.698.75163.62
Upgrade
Other Long-Term Liabilities
0.02----
Upgrade
Total Liabilities
336.89352.86392.52319.24373.15
Upgrade
Common Stock
0.010.010.010.010.01
Upgrade
Additional Paid-In Capital
1,5061,4531,3871,3241,254
Upgrade
Retained Earnings
-1,304-1,144-919.08-718.89-511.61
Upgrade
Comprehensive Income & Other
0.170.22-4.12-1.140.89
Upgrade
Total Common Equity
202.71308.4464.17603.99743.27
Upgrade
Minority Interest
-0.22-0.12-0.070.11-
Upgrade
Shareholders' Equity
202.49308.28464.1604.1743.27
Upgrade
Total Liabilities & Equity
539.38661.13856.62923.341,116
Upgrade
Total Debt
222.67229.43233.36111.74107.86
Upgrade
Net Cash (Debt)
33.29116.97264.83458.47698.93
Upgrade
Net Cash Growth
-71.54%-55.83%-42.23%-34.41%8.24%
Upgrade
Net Cash Per Share
0.230.811.863.275.33
Upgrade
Filing Date Shares Outstanding
148.58145.09143.23141.58139.22
Upgrade
Total Common Shares Outstanding
147.77145.08143.11141.39137.65
Upgrade
Working Capital
185.7322.17452.36288.94621.72
Upgrade
Book Value Per Share
1.372.133.244.275.40
Upgrade
Tangible Book Value
80.31184.3338.37476.49614.07
Upgrade
Tangible Book Value Per Share
0.541.272.363.374.46
Upgrade
Machinery
59.3361.3656.748.8834.08
Upgrade
Construction In Progress
2.573.417.635.667.19
Upgrade
Leasehold Improvements
73.2874.7372.465.9621.95
Upgrade
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q